we enrolled 479 patients with subarachnoid hemorrhage in a multicenter , randomized , double-blind , placebo-controlled trial to determine whether treatment with the antifibrinolytic agent tranexamic acid improves outcome by preventing rebleeding .
C0038525
subarachnoid hemorrhage
C0040613
tranexamic acid